These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 25327580)

  • 1. Programmed necrosis and necroptosis signalling.
    Feoktistova M; Leverkus M
    FEBS J; 2015 Jan; 282(1):19-31. PubMed ID: 25327580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIPK1 and RIPK3: critical regulators of inflammation and cell death.
    Newton K
    Trends Cell Biol; 2015 Jun; 25(6):347-53. PubMed ID: 25662614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
    Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H
    Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Insights into the Mechanism of Necroptosis: The Necrosome As a Potential Therapeutic Target.
    Chen J; Kos R; Garssen J; Redegeld F
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Receptor Interacting Protein Kinases in the Liver.
    Dara L
    Semin Liver Dis; 2018 Feb; 38(1):73-86. PubMed ID: 29471568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIPK1 inhibits ZBP1-driven necroptosis during development.
    Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
    Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed necrosis in inflammation: Toward identification of the effector molecules.
    Wallach D; Kang TB; Dillon CP; Green DR
    Science; 2016 Apr; 352(6281):aaf2154. PubMed ID: 27034377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis.
    Rodriguez DA; Weinlich R; Brown S; Guy C; Fitzgerald P; Dillon CP; Oberst A; Quarato G; Low J; Cripps JG; Chen T; Green DR
    Cell Death Differ; 2016 Jan; 23(1):76-88. PubMed ID: 26024392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necroptosis, in vivo detection in experimental disease models.
    Jouan-Lanhouet S; Riquet F; Duprez L; Vanden Berghe T; Takahashi N; Vandenabeele P
    Semin Cell Dev Biol; 2014 Nov; 35():2-13. PubMed ID: 25160988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis.
    Moriwaki K; Chan FK
    Int Rev Cell Mol Biol; 2017; 328():253-275. PubMed ID: 28069136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24(S)-Hydroxycholesterol induces RIPK1-dependent but MLKL-independent cell death in the absence of caspase-8.
    Vo DK; Urano Y; Takabe W; Saito Y; Noguchi N
    Steroids; 2015 Jul; 99(Pt B):230-7. PubMed ID: 25697054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necroptosis is preceded by nuclear translocation of the signaling proteins that induce it.
    Yoon S; Bogdanov K; Kovalenko A; Wallach D
    Cell Death Differ; 2016 Feb; 23(2):253-60. PubMed ID: 26184911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ripoptosome: a novel IAP-regulated cell death-signalling platform.
    Imre G; Larisch S; Rajalingam K
    J Mol Cell Biol; 2011 Dec; 3(6):324-6. PubMed ID: 22114055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of RIPK3 predicts necroptosis resistance in malignant melanoma.
    Geserick P; Wang J; Schilling R; Horn S; Harris PA; Bertin J; Gough PJ; Feoktistova M; Leverkus M
    Cell Death Dis; 2015 Sep; 6(9):e1884. PubMed ID: 26355347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling.
    Sessler T; Healy S; Samali A; Szegezdi E
    Pharmacol Ther; 2013 Nov; 140(2):186-99. PubMed ID: 23845861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis.
    Kearney CJ; Cullen SP; Clancy D; Martin SJ
    FEBS J; 2014 Nov; 281(21):4921-34. PubMed ID: 25195660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.
    Newton K; Dugger DL; Wickliffe KE; Kapoor N; de Almagro MC; Vucic D; Komuves L; Ferrando RE; French DM; Webster J; Roose-Girma M; Warming S; Dixit VM
    Science; 2014 Mar; 343(6177):1357-60. PubMed ID: 24557836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necroptosis signaling in liver diseases: An update.
    Saeed WK; Jun DW; Jang K; Koh DH
    Pharmacol Res; 2019 Oct; 148():104439. PubMed ID: 31476369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necroptosis in development, inflammation and disease.
    Weinlich R; Oberst A; Beere HM; Green DR
    Nat Rev Mol Cell Biol; 2017 Feb; 18(2):127-136. PubMed ID: 27999438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of necroptosis in pulmonary diseases.
    Mizumura K; Maruoka S; Gon Y; Choi AM; Hashimoto S
    Respir Investig; 2016 Nov; 54(6):407-412. PubMed ID: 27886851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.